Stryker (SYK) Shares Outstanding (2009 - 2026)
Stryker's (SYK) quarterly Shares Outstanding (Entity) came in at $383.4 million in Q1 2026, little changed year-on-year from $382.2 million in Q1 2025, and little changed on a QoQ basis from $382.7 million in Q4 2025.
Stryker (SYK) Shares Outstanding (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Shares Outstanding (Entity) data on file, last reported at $383.4 million in Q1 2026.
- On a quarterly basis, Shares Outstanding (Entity) changed 0.31% year-over-year to $383.4 million in Q1 2026; TTM through Mar 2026 was $383.4 million, a 0.31% change from a year earlier, with the FY2025 full-year figure at $382.7 million, changed 0.29% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $383.4 million, roughly flat from $382.7 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for SYK reached as high as $383.4 million in Q1 2026 and fell as low as $378.2 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $380.6 million across 5 years, with a median of $380.9 million in 2024.
- Across the five-year window, Shares Outstanding (Entity) increased 0.39% in 2023 and climbed 0.29% in 2025, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $378.8 million in 2022, then rose by 0.38% to $380.3 million in 2023, then gained by 0.35% to $381.6 million in 2024, then grew by 0.29% to $382.7 million in 2025, then rose by 0.18% to $383.4 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $383.4 million in Q1 2026, $382.7 million in Q4 2025, and $382.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 98.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 382.90 Mn |
| Dec 31, 2025 | 382.20 Mn |
| Sep 30, 2025 | 382.40 Mn |
| Jun 30, 2025 | 382.20 Mn |
| Mar 31, 2025 | 381.70 Mn |
| Dec 31, 2024 | 381.00 Mn |
| Sep 30, 2024 | 381.10 Mn |
| Jun 30, 2024 | 381.00 Mn |
| Mar 31, 2024 | 380.40 Mn |
| Dec 31, 2023 | 379.60 Mn |
| Sep 30, 2023 | 379.80 Mn |
| Jun 30, 2023 | 379.70 Mn |
| Mar 31, 2023 | 379.00 Mn |
| Dec 31, 2022 | 378.20 Mn |
| Sep 30, 2022 | 378.40 Mn |
| Jun 30, 2022 | 378.30 Mn |
| Mar 31, 2022 | 377.70 Mn |
| Dec 31, 2021 | 377.00 Mn |
| Sep 30, 2021 | 377.10 Mn |
| Jun 30, 2021 | 376.90 Mn |